Lars Christian Biilmann Rønn,Ibrahim John Malik,Jeffrey B. Stavenhagen,Søren Christensen,Jan Egebjerg,Arnout Gerritsen,Edward van den Brink,Paul Parren,Rob de Jong
申请号：
US16521279
公开号：
US20200190188A1
申请日:
2019.07.24
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to monoclonal anti-Sortilin antibodies which have been found useful in correcting a deficient level of progranulin (PGRN). In particular, these antibodies can be used in the treatment of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).
